Shannon Babcock received her Bachelor’s of Science in Biochemistry from Gonzaga University in 2017 and has recently earned her PhD in Molecular and Medical Genetics from the Oregon Health and Science University in Portland, OR. While at OHSU, Shannon studied the molecular mechanisms involved with and potential treatments for LCHADD chorioretinopathy using a novel LCHADD mouse model. Since graduating in May 2024, Shannon has begun a laboratory genetics and genomics fellowship at the Henry Ford Hospital in Detroit, MI where she is working to become a clinical lab geneticist. In her free time, Shannon enjoys playing tennis and spending time outdoors with her dog.
